University of Alabama at Birmingham
1,745
277
381
1,005
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
13.5%
235 terminated/withdrawn out of 1745 trials
81.0%
-5.5% vs industry average
10%
177 trials in Phase 3/4
43%
434 of 1005 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (1745)
Effectiveness of a Smoking Cessation Algorithm Integrated Into HIV Primary Care
Role: lead
COMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomide
Role: lead
STROKE STAT (Stroke Severity-based Triage to Accelerate Treatment)
Role: lead
Remote vs. In-Person Study Evaluation (RISE) Trials: RISE Above Smoking (Trial 1)
Role: collaborator
LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma
Role: collaborator
OMEGA-3-FATTY ACIDS IN CHILDREN WITH SICKLE CELL DISEASE
Role: lead
A Bundled Intervention to End Opioid Overdoses
Role: lead
Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
Role: lead
"Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)"
Role: lead
Remote Fentanyl Test Strip Distribution and Education to Prevent Drug Overdose
Role: lead
Adapted High-Intensity Virtual Reality Exergaming
Role: lead
Health Disparities on the Labor Floor
Role: lead
Constraint-Induced Movement Therapy Plus Sensory Components After Stroke
Role: lead
Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease
Role: lead
UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy
Role: lead
VENTURI (VENTilation Using Respiratory Imaging)
Role: lead
ME/CFS Brain Fog: Cognitive Rehabilitation Trial
Role: lead
Long COVID Brain Fog: Cognitive Rehabilitation Trial
Role: lead
Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland Dysfunction
Role: lead
Kuwa Free! - Live Free!
Role: lead